1. Home
  2. LYEL vs LWAY Comparison

LYEL vs LWAY Comparison

Compare LYEL & LWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lyell Immunopharma Inc.

LYEL

Lyell Immunopharma Inc.

HOLD

Current Price

$12.57

Market Cap

401.8M

Sector

Health Care

ML Signal

HOLD

LWAY

Lifeway Foods Inc.

HOLD

Current Price

$23.04

Market Cap

368.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LYEL
LWAY
Founded
2018
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
401.8M
368.4M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
LYEL
LWAY
Price
$12.57
$23.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$30.60
$34.50
AVG Volume (30 Days)
61.8K
151.3K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
48.33
EPS
N/A
0.30
Revenue
$36,000.00
$103,350,000.00
Revenue This Year
N/A
$16.64
Revenue Next Year
$8,712.13
$17.28
P/E Ratio
N/A
$75.30
Revenue Growth
N/A
N/A
52 Week Low
$8.49
$17.31
52 Week High
$45.00
$34.20

Technical Indicators

Market Signals
Indicator
LYEL
LWAY
Relative Strength Index (RSI) 22.77 38.83
Support Level $12.15 $21.11
Resistance Level $13.62 $27.88
Average True Range (ATR) 1.36 1.25
MACD -0.27 -0.34
Stochastic Oscillator 3.08 13.94

Price Performance

Historical Comparison
LYEL
LWAY

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc s a late-stage clinical cell therapy company advancing a pipeline of proprietary next-generation autologous chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The Company's product candidate, rondecabtagene autoleucel (ronde-cel, also known as LYL314), is an autologous dual-targeting CD19/CD20 CAR T-cell therapy in development for large B-cell lymphoma (LBCL). The Company has recently acquired exclusive rights outside of mainland China, Hong Kong, Macau and Taiwan, to a novel guanylyl cyclase C (GCC)-targeted CAR T-cell product candidate in early clinical development for refractory metastatic colorectal cancer (mCRC) and other GCC-expressing cancers.

About LWAY Lifeway Foods Inc.

Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.

Share on Social Networks: